Overweight and/or ObesityBITE-INCT07592728
Brief Inhibitory Training for Eating - Intervention
A study of Overweight and/or Obesity, run by George Mason University at 1 site in United States.
Trial summary
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training. Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life. Read more about this study
- Who is it for?
- Ages 14 to 17 years
- Conditions the study is for
- Overweight and/or Obesity
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteUnited States
- Study dates
- 1 May 2026to 10 Mar 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 17 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- 14-17 years old
- Have overweight or obesity (BMI-z≥85th percentile)
- Have a smartphone
- Can read and speak English
- Interest in improving one's diet.
Who cannot join
- Not currently in eating disorder or weight loss treatment or receiving pharmacological/surgical treatment for obesity in the past four weeks
- Not meeting criteria for atypical anorexia nervosa or bulimia nervosa
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
George Mason University
Fairfax, Virginia, 22030
Tyler Mason
About this study
Official title: Inhibitory Control Training for Adolescents
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training.
Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life.
Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation.
In the study, participants will:
Complete questionnaires and cognitive tasks Receive a short nutrition education Complete three weeks of daily brain games on your phone
- Conditions
- Overweight and/or Obesity
- Being tested
- Daily inhibitory control training
- Keywords
- obesity, adolescent, nutrition, eating behavior
- Medical subject headings
- Obesity, Feeding Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Daily inhibitory control trainingBehavioural
Children will first complete a short nutrition education then complete daily 10-minute inhibitroy control training each day for 10 minutes across 3 weeks
| Study group | Role | What they receive |
|---|---|---|
| Inhibitory control training | Experimental | Not described Receives: Behavioral: Daily inhibitory control training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Inhibitory control
Go-No/Go Task with food cues
Measured: 1 month
Eating self-regulation
Self-Regulation of Eating Behaviour Questionnaire
Measured: 1 month
Secondary outcomes (2)
Binge-eating symptoms
Eating Pathology Symptom Inventory
Measured: 1 month
Diet Quality
Mini-EAT
Measured: 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 May 2026
- Study start1 May 2026
- Primary completion10 Feb 2027 (estimated)
- Study completion10 Mar 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Overweight and/or ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 36 participants (estimated)
Sponsor and investigators
- Lead sponsor
- George Mason University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Tyler B Mason, George Mason University
- Investigators
- Tyler Mason, PhD, Principal investigator, George Mason University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07592728
- Sponsor's protocol ID
- STUDY00001112
- Acronym
- BITE-I
- Status last verified
- Jun 2026
- First submitted
- 6 Apr 2026
- Last updated
- 17 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: All IPD collected throughout the trial
Study at a glance
From the registry record, last updated by the sponsor on 17 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Inhibitory Control Training for Adolescents
- ClinicalTrials.gov ID
- NCT07592728
- Acronym / sponsor ID
- BITE-I / STUDY00001112
- Conditions
- Overweight and/or Obesity
- Keywords
- obesity, adolescent, nutrition, eating behavior
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 36 participants (estimated)
- Lead sponsor
- George Mason UniversityUniversity, hospital or other
- Study start
- 1 May 2026 (actual)
- Primary completion
- 10 Feb 2027 (estimated)
- Study completion
- 10 Mar 2027 (estimated)
- First posted
- 18 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training.
Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life.
Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation.
In the study, participants will:
Complete questionnaires and cognitive tasks Receive a short nutrition education Complete three weeks of daily brain games on your phone
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Inhibitory control training | Experimental | Behavioral: Daily inhibitory control training |
Who may qualify
- Ages
- 14 to 17 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (5 listed)
- 14-17 years old
- Have overweight or obesity (BMI-z≥85th percentile)
- Have a smartphone
- Can read and speak English
- Interest in improving one's diet.
Key exclusion criteria (2 listed)
- Not currently in eating disorder or weight loss treatment or receiving pharmacological/surgical treatment for obesity in the past four weeks
- Not meeting criteria for atypical anorexia nervosa or bulimia nervosa
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Daily inhibitory control trainingChildren will first complete a short nutrition education then complete daily 10-minute inhibitroy control training each day for 10 minutes across 3 weeks | Behavioural | Inhibitory control training |
Primary outcome
Inhibitory control
Time frame: 1 month
Go-No/Go Task with food cues
Eating self-regulation
Time frame: 1 month
Self-Regulation of Eating Behaviour Questionnaire
2 secondary outcomes
Binge-eating symptoms
Time frame: 1 month
Diet Quality
Time frame: 1 month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Jun 2026.
- Individual participant dataSharing planned: Yes. All IPD collected throughout the trial
Related trials for Overweight and/or Obesity
RecruitingPhase 1/2
A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
Overweight and Obesity
RecruitingObservational study
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Metabolic Disease, Obesity
RecruitingPhase 2
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Overweight or Obesity
Not yet recruitingPhase 3
Efficacy And Safety of Olatorepatide in Adults With Overweight or Obesity Without Diabetes
Overweight or Obesity Without Diabetes
Recruiting
iWAIST Trial: ERCG (Endoscopic Radial Compression Gastroplasty) +Optimized Lifestyle Intervention (OLI) vs Sham + OLI for Weight Loss
Overweight and/or Obesity, Metabolic Syndrome
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Tyler Mason, PhD principal investigator
George Mason University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study of Overweight and/or Obesity, run by George Mason University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 17 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Tyler Mason, PhD (703-993-1000, tmason24@gmu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Inhibitory control (time frame: 1 month). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2026.